New research by a Florida State University chemistry professor uses some of the world's most powerful magnets to put a bullseye on the flu virus. Led by professor of chemistry and biochemistry Tim Cross and his team at the Florida State University-based National High Magnetic Field Laboratory, scientists delved into the complexities of exactly how the flu virus works and why it's so effective at making people so sick. With a better understanding of how it works, researchers will now be able to turn their attention to creating more effective prescription drugs to fight the flu.
Cross and his team were able to detail the mechanism that activates the flu virus permitting it to reproduce in a human cell. They laid out their findings in the academic journal Structure.
"If we can get a drug that disrupts this mechanism, that would be huge," Cross says. "We really don't know when a deadly flu epidemic is going to hit next. We need backup to vaccines."
But to create those drugs, scientists needed to first understand how the virus functions on its most basic level.
The influenza virus is what's known as an enveloped virus, meaning it has a membrane coat, similar to the way a cell has a membrane. In that membrane are three different proteins, one of which is called the M2 proton channel.
As the virus moves into a cell, it enters an acidic environment, which activates the M2 proton channel. Once the M2 proton channel is activated, protons move through the channel and compel the membrane coat to fuse to the host membrane, causing infection and ultimately, reproduction of the virus.
Using the National MagLab's most sensitive nuclear magnetic resonance magnet -- essentially a super powered MRI -- scientists were able to get a clear image of the channel and how protons moved through it causing the fusion of the virus with the host membranes.
"We can actually see the protons move," Cross says. "Nobody thought we would be able to do this."
For years, scientists worldwide have been fixated on how this channel works because it provides the basic clues to understanding how viral infection works. The M2 channel has long been a target of drug developers, but when the swine flu broke out in 2009, doctors quickly discovered that drugs that had been in use for decades suddenly didn't work.
"The drugs didn't work anymore," Cross says. "As in so many cases, the virus had evolved. So, there's a lot of interest in studying this protein and seeing if we can develop a new antibiotic."
Cross' work was funded by the National Institutes of Health and the National Science Foundation.
The paper's co-authors are Professor of Physics Huan-Xiang Zhou, MagLab scientist Riqiang Fu and former FSU graduate student Yimin Miao.
Source: Florida State University
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.